HopeStage
Back to all studies
CompletedNCT01342445

Effects of LDX on Functioning of College Students With ADHD

It focuses on ADHD and currently lists study information in the United States.

ADHDDrugFrom 18 Years to 28 Years
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 28 years.

Listed locations
Bethlehem, United States · Kingston, United StatesSee all locations and recruitment

Compensation and expense reimbursement have not been verified for this summary.

Study clarity

Study information

Study start dateSeptember 2009
Recruitment status
Completed
Enrollment listed in the registry
50
Sponsor
University of Rhode Island
Sponsor type
University
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 28 Years
Official registry ID
NCT01342445
Official title
Effects of Vyvanse on the Behavioral, Academic, and Psychosocial Functioning of College Students With ADHD

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Bethlehem · Kingston

FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Rhode Island, a university.

Did this study involve medication?

Yes. The study involved medication, including lisdexamfetamine dimesylate and Placebo.

Who was this study for?

Listed age limits: 18 years to 28 years.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me